InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,612.00
(
0.00%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
81.90
(
-1.17%
)
Bitcoin
62,197.82
(
-0.22%
)
Post# of 1530
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Letterpenny

Send PM Follow Ignore
Followers 6
Posts 5991
Boards Moderated 0
Alias Born 06/27/2018

Letterpenny

Member Level

Re: None

Tuesday, 06/27/2023 6:33:22 PM

Tuesday, June 27, 2023 6:33:22 PM

Post# of 1530
See how they listed. Proof is in the pudding.

Item 8.01 Other Events.

On August 20, 2013, EpiCept Corporation announced that its 1-for-40 reverse stock split and change of corporate name to Immune Pharmaceuticals Inc. would become effective at 5:00 p.m. EDT on August 20, 2013, and that trading of its common stock on a post-split basis would begin on the Nasdaq OMX Stockholm Exchange and the OTCQX U.S. trading platform on August 21, 2013. The press release is attached hereto as Exhibit 99.1.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up